Operational momentum behind Houlihan Lokey’s recent stock move

Houlihan Lokey (HLI) has drawn fresh attention after recent coverage highlighted strong revenue and earnings per share growth, rising market share, and steady gains in tangible book value over the last two years.

At a share price of $140.77, Houlihan Lokey’s recent 7 day share price return of 2.09% sits against a 30 day share price decline of 7.16% and a year to date share price decline of 20.17%. The 5 year total shareholder return of 90.63% points to much stronger longer term performance and suggests recent weakness may reflect a reset in expectations after a robust multi year run.

If Houlihan Lokey’s recent move has you thinking about where else the market is rewarding durable business models, it could be a good moment to broaden your search with the 20 top founder-led companies

With Houlihan Lokey shares down 20.17% year to date, yet trading at a 27.60% discount to one intrinsic value estimate and a 22.54% discount to a US$172.50 analyst target, is this a genuine opportunity or is the market already pricing in future growth?

Most Popular Narrative: 18.4% Undervalued

With Houlihan Lokey trading at $140.77 against a narrative fair value of $172.50, the current price sits well below what the most followed narrative models in using a 7.8% discount rate.

Increasing global corporate complexity and cross-border transactions are driving ongoing demand for independent advisory expertise, as evidenced by resilient revenues and continued international hiring and expansion initiatives. These factors are expected to support sustained top-line revenue growth.

Want to see what underpins that upside gap for Houlihan Lokey? The narrative leans heavily on steady revenue compounding, stable margins, and a richer earnings multiple. The full story is in the detailed projections and how they connect to that long term earnings path.

Result: Fair Value of $172.50 (UNDERVALUED)

However, Houlihan Lokey’s story can shift quickly if US focused M&A pipelines stay muted, or if higher compensation costs start to squeeze margins more than expected.

Next Steps

If the Houlihan Lokey story sounds promising but complex, now is the time to review the numbers yourself and pressure test the optimism around its 5 key rewards.

Looking for more investment ideas beyond Houlihan Lokey?

If Houlihan Lokey has sharpened your focus on quality, do not stop here. Use the Simply Wall St Screener to uncover other opportunities that might suit your portfolio.

• Spot potential upside in companies the market may be overlooking by reviewing the 45 high quality undervalued stocks and comparing their fundamentals for yourself.
• Prioritise resilience and sleep easier at night by scanning the 65 resilient stocks with low risk scores for stocks with steadier risk profiles.
• Hunt for future standouts before they become widely followed by checking the screener containing 19 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.